ENDOLOGIX INC /DE/ Restructuring and Related Cost, Expected Cost
ENDOLOGIX INC /DE/ had Restructuring and Related Cost, Expected Cost of $16.70 million as of 2019-12-31, per its 10-K filed 2020-03-11.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringAndRelatedCostExpectedCost1 · last filed 2020-03-11
- 2019-12-31: Restructuring and Related Cost, Expected Cost $16.70M.
- 2018-12-31: Restructuring and Related Cost, Expected Cost $16.20M.
- 2017-12-31: Restructuring and Related Cost, Expected Cost $12.60M.
- 2017-09-30: Restructuring and Related Cost, Expected Cost $11.30M.
| Period end | Restructuring and Related Cost, Expected Cost |
|---|---|
| 2019-12-31 | $16.70M 10-K · filed 2020-03-11 |
| 2018-12-31 | $16.20M 10-K · filed 2019-04-01 |
| 2017-12-31 | $12.60M 10-K · filed 2018-03-13 |
| 2017-09-30 | $11.30M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $11.20M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $11.30M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $11.30M 10-K · filed 2017-03-01 |
| 2016-09-30 | $9.00M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $9.30M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $9.30M 10-Q · filed 2016-05-10 |